I doubt it. While I have not sold my remaining stake (many thousands of shares, quite a significant holding still), I expect a "slow bleed" that will take us lower. I'm not predicting single digits or anything like that (in the absence of any news, at least), but from $13.31, I do expect that we will see $12's at some point.
October is coming, and there's a chance for an Intel XDR roadmap announcement at IDF (end of August), but under any circumstances, from what I can see, the FORSEEABLE next 30 days look to be devoid of any signficant news either way. And we have seen all too often how this stock does in the absence of news.
I bought 4,000 shares of ELN today (about $7.60). A drug company rumored to be on the verge of some great things, it's a roller-coaster ride like Rambus. Was $30 in the past few months, then dropped to $3 when one of it's promising new drugs showed some undesireable side effects (nothing major, just death). However it now appears that the problem was due to an interaction with another drug that can be easily dealt with, now that it's known about.